Novel neutral antibodies are found targeting the SARS-CoV-2 N-terminal domain
The main thrust of a scientific study of therapeutic therapy to combat chronic coronavirus disease 2019 (COVID-19) has focused on identifying drugs and antibodies that may counteract the entry of t…
